How Sleep and Genes Together Influence Early Alzheimer Changes

Sleep Genes

Scientists at Edith Cowan University found that the way we sleep and a tiny part of our DNA work together to change the brain long before Alzheimer’s shows up.

The study looked at a gene called aquaporin‑4 (AQP4). This gene helps move fluid in the brain, which is needed for the brain’s cleaning system.

The brain cleans itself while we sleep

During sleep the brain clears out waste, including proteins that can cause Alzheimer’s. The cleaning gets stronger at night.

People who have certain versions of the AQP4 gene lose brain tissue faster if they sleep less.

“It’s not just the gene alone,” said Dr. Ayeisha Milligan Armstrong. “It’s how the gene works with a person’s sleep. The same gene can be good or bad depending on sleep habits.”

The brain area called grey matter holds many cells for memory, thinking, and movement. Losing grey matter can mean the brain is changing in a harmful way.

Different genes, different sleep effects

The team examined 13 common AQP4 variants, along with how many hours participants slept, brain scans, and memory tests.

For some people, sleeping fewer hours meant their grey matter shrank faster. For others, taking longer to fall asleep was linked to smaller brain size.

Memory scores also changed in different ways, depending on the gene version a person carried.

Dr. Tenielle Porter added, “We know bad sleep raises Alzheimer’s risk. This study tells us that the risk may follow different paths for different people.”

Moving toward personalized prevention

The research suggests two people with the same overall risk might react differently to poor sleep because of their genes.

Future studies should include genetic information to see if better sleep can protect those who are genetically vulnerable.

Professor Simon Laws said, “Finding who is most at risk and who will benefit from sleep improvements is the next step for precision health.”

The study, titled “Evidence for Direct and Sleep‑Moderated Relationships between Aquaporin‑4 Genetic Variants and Alzheimer’s Disease Phenotypes,” was published in Alzheimer’s & Dementia, the journal of the Alzheimer’s Association.